Department of Endocrinology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Department of Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran.
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102149. doi: 10.1016/j.dsx.2021.05.022. Epub 2021 May 21.
Identifying the predictors of COVID-19 related death in diabetes patients can assist physicians for detecting risk factors related to the worse outcome in these patients. In this study we investigated the predictors of the death in patients with diabetes compared with non-diabetic COVID-19 patients.
In the present case-control study, the case group were diabetic patients with COVID-19 and the control group included Non-diabetic COVID-19 patients. The data source regarding the demographic characteristics, clinical symptoms, laboratory, and radiological findings on admission as well as the complications, treatment, and outcomes during hospitalization were gathered from their medical record through two trained nurses. Adjusted and unadjusted odds ratios (OR) estimate were calculated using the simple and multiple logistic regression through backward model.
The mean (SD) age of the case group was higher than that of the control group; [65.24 (12.40) years vs. 59.35 (17.34) years, respectively (P < 0.001)]. Results of the adjusted logistic regression model showed that, advanced age (+60 year) (OR = 5.13, P = 0.006), addiction (OR = 5.26, P = 0.033), high level of Blood urea nitrogen (OR = 5.85, P < 0.001), and high level of Alkaline Phosphatase (OR = 3.38, P = 0.012) in diabetic patients were significantly associated with increase the odds of death in COVID-19 patients.
We found that in COVID-19 patients with diabetes; advanced age, addiction, high level of BUN and Alp and in non-diabetic COVID-19 patients advanced age, dyspnea, high level of BUN and SGOT were associated with increase risk of death in these patients.
识别与糖尿病患者 COVID-19 相关死亡相关的预测因素,可以帮助医生发现与这些患者预后较差相关的危险因素。在这项研究中,我们调查了与非糖尿病 COVID-19 患者相比,糖尿病患者 COVID-19 死亡的预测因素。
本病例对照研究中,病例组为糖尿病合并 COVID-19 患者,对照组为非糖尿病 COVID-19 患者。通过两名经过培训的护士从他们的病历中收集有关人口统计学特征、入院时的临床症状、实验室和影像学发现以及住院期间的并发症、治疗和结局的数据。使用简单和多元逻辑回归通过向后模型计算调整和未调整的比值比(OR)估计。
病例组的平均(SD)年龄高于对照组;[65.24(12.40)岁比 59.35(17.34)岁,分别(P<0.001)]。调整后的逻辑回归模型结果显示,高龄(≥60 岁)(OR=5.13,P=0.006)、成瘾(OR=5.26,P=0.033)、高血尿素氮(OR=5.85,P<0.001)和高碱性磷酸酶(OR=3.38,P=0.012)水平与糖尿病患者 COVID-19 患者死亡风险增加显著相关。
我们发现,在 COVID-19 合并糖尿病患者中,高龄、成瘾、高血尿素氮和碱性磷酸酶水平以及非糖尿病 COVID-19 患者的高龄、呼吸困难、高血尿素氮和 SGOT 水平与这些患者的死亡风险增加相关。